New CRISPR test aims to speed up sepsis diagnosis and save lives in the ICU
NCT ID NCT07580001
First seen May 18, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This study looks at a new rapid test called NuRapid-CRISPR that quickly finds the germs causing sepsis in ICU patients. It compares the test's accuracy to standard lab cultures and checks if using the test's fast results to guide treatment can lower the chance of death within 28 days. About 396 adults with suspected sepsis will take part. The goal is to see if faster diagnosis leads to better outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Critical Care Medicine, Tongji Hospital, Shanghai
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Shanghai Dongfang Hospital
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Yangpu District Central Hospital, Shanghai
Shanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.